---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-075385"
form_type: "8-K"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:00:12.250105+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Veracyte registers 1,016,965 shares for resale relating to C2i Genomics acquisition

## Summary
- Filed prospectus supplement to register 1,016,965 shares of common stock for resale.
- Shares were issued as part of the consideration for the February 5, 2024 acquisition of C2i Genomics.
- Legal opinion from Fenwick & West LLP regarding the legality of the registered shares filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001193125-24-075385
- form_type: 8-K
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000119312524075385/0001193125-24-075385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000119312524075385/d735520d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-075385
- JSON: https://secwatch.observer/filing/0001193125-24-075385.json
- Plain text: https://secwatch.observer/filing/0001193125-24-075385.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.